Show simple item record

dc.contributor.authorWorld Health Organization, Regional Office for South-East Asia
dc.coverage.spatialNew DelhiEN
dc.date.accessioned2014-07-19T09:57:52Z
dc.date.available2014-07-19T09:57:52Z
dc.date.copyrightWorld Health Organization
dc.date.issued2012-07-19
dc.identifier.govdocSEA/RC65/12
dc.identifier.urihttps://apps.who.int/iris/handle/10665/128316
dc.description.abstractThe Consultative Expert Working Group on Research and Development: Financing and Coordination (‎CEWG)‎ set up by the World Health Assembly presented its report in May 2012. This CEWG report has made a number of proposals to improve current financing and coordination of research and development including proposals for new and innovative sources of financing to stimulate research and development related to type II and type III diseases and the specific research and development needs of developing countries in relation to type I diseases. The proposals received were consolidated into 15 groups which the CEWG assessed based on criteria summarized under the headings of public health impact, technical, financial and implementation feasibility. Consultations were held in five WHO tegions and in the South- East Asia Region these took place on 7 October 2011 in New Delhi. The proposals were further grouped into three sets: those meeting the criteria less well; those not principally contributing to improved financing or coordination of research and development (‎R&D)‎; and those that CEWG felt best met the criteria. Based on detailed analysis, CEWG has recommended a coordination function under the auspices of WHO that would include: (‎1)‎ a global health research and development (‎R&D)‎ observatory to collect and analyse data, including in the areas of financial flows to R&D; and (‎2)‎ advisory mechanisms – a network of research institutions and funders that may include specialized sections according to the subject of research. The CEWG underlines the issue of securing sustainable financing would be essential for achieving the goals for which a number of options have been discussed. Countries could fulfil their financial commitment through contributions to a financing mechanism established under a proposed R&D convention. For sustained funding the CEWG recommends all countries should commit to spend at least 0.01% of GDP on government-funded R&D devoted to meeting the health needs of developing countries. In addition countries should consider these targets: developing countries with a potential research capacity should aim to commit 0.05−0.1% of GDP to government-funded health research of all kinds, and developed countries should aim to commit 0.15−0.2% of GDP to government-funded health research of all kinds. The CEWG suggested a framework for negotiation of an R&D convention based on Article 19 of the WHO Constitution for which a working group composed of two members from each WHO region may be established. Alternatively, an open-ended intergovernmental working group could be established. The World Health Assembly should also provide for an intergovernmental negotiating body open to all Member States to be established under Rule 40 of the World Health Assembly’s Rules of Procedure. The recommendations of the CEWG are presented for consideration and for identifying priority areas for Member States in the Region. The attached working paper was submitted to the High-Level Preparatory (‎HLP)‎ Meeting held during 2-5 July 2012 for its review and recommendations. The HLP made the following recommendations: Actions by Member States (‎1)‎ To take the lead in national and regional consultations and actively engage in the global negotiations for developing financing and coordinating mechanisms to promote financing and coordinating mechanisms for research and development (‎R&D)‎ for type II and type III diseases and specific R&D needs for type I diseases, based on the CEWG report and other relevant analysis. Member States have flexibilities in developing national and regional positions in the IGM negotiation so that the CEWG recommendations are taken forwards in the best interest of Member States in the Region. (‎2)‎ To implement, where feasible, in their respective countries, proposals and actions identified by national consultations, and to establish and/or strengthen mechanisms for improved coordination of R&D including an increase in investments in health R&D in collaboration with WHO and other relevant partners including the private sector, academic institutions and nongovernmental organizations. Actions by WHO-SEARO (‎1)‎ To support Member States in national and regional consultations and global negotiations based on the CEWG report for developing financing and coordinating mechanisms for promoting R&D in the context of the implementation of the Global Strategy and Plan of Action on Public Health, Innovation and Intellectual Property. The working paper and the HLP recommendations are submitted to the Sixty-fifth Regional Committee for its consideration.EN
dc.languageEnglish
dc.language.isoenEN
dc.publisherWHO Regional Office for South-East AsiaEN
dc.titleSEA/RC65/12 - Reports of WHO global working/advisory groups: Consultative Expert Working Group on Research and Development: Financing and CoordinationEN
dc.typeGoverning body documentsEN


Files in this item

Thumbnail

This item appears in the following Collection(‎s)‎

Show simple item record